Skip to main content
ImmuneCited

Açıklama

Matrix metalloproteinase (MMP) activity was reduced by quercetin treatment in vitro, indicating suppression of extracellular matrix remodeling associated with angiogenesis.

Figure 4

Chart

Source Paper

Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.

Medicines (Basel, Switzerland) (2021)

PMID: 34065895

DOI: 10.3390/medicines8050022

Cite This Figure

![Figure 4: Matrix metalloproteinase (MMP) activity was reduced by quercetin treatment in vitro, indicating suppression of extracellular matrix remodeling associated with angiogenesis.]()

> Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." *Medicines (Basel, Switzerland)*, 2021. PMID: [34065895](https://pubmed.ncbi.nlm.nih.gov/34065895/)
<figure>
  <img src="" alt="Matrix metalloproteinase (MMP) activity was reduced by quercetin treatment in vitro, indicating suppression of extracellular matrix remodeling associated with angiogenesis." />
  <figcaption>Figure 4. Matrix metalloproteinase (MMP) activity was reduced by quercetin treatment in vitro, indicating suppression of extracellular matrix remodeling associated with angiogenesis.<br>  Source: Takayuki Okumo et al. "Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo.." <em>Medicines (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34065895/">34065895</a></figcaption>
</figure>